	Incremental Value of Synthetic MRI Radiomics in Predicting Neoadjuvant Response in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer. Radiol Imaging Cancer Chen S, Chen Y, Jin C, Zheng B, Ding S, Weng Z, Tang W, Liu W, Lin Y, Kong Q, Zhou Q, Guo Y. PMID: 42599169 [PubMed - indexed for MEDLINE]
	Neutrophil-lymphocyte ratio as prognostic factor in metastatic breast cancer. Rev Bras Ginecol Obstet Dos Santos GMC, Costa-Lima NK, Tiezzi IDM, Pavão GK, Silva IG, Maia PM, Carrara HHA, Tiezzi DG. PMID: 42598663 [PubMed - indexed for MEDLINE]
	Intraoperative Imprint Cytology Versus Frozen Section for Sentinel Lymph Node Assessment in Breast Carcinoma: A Prospective Diagnostic Accuracy Study From a Resource-Limited Setting in Eastern India. Cureus Mishra A, Paswan MK, Debnath S, Jamaiyar A, Shome A. PMID: 42598258 [PubMed]
	Talking about alcohol to patients (TAP) study: Assessing patient-provider communication of alcohol's breast cancer risks. Prev Med Rep Abed S, Aly S, Trulove G, Ganesan V, Martinez P, Aneja R. PMID: 42598039 [PubMed]
	A genome-wide association study on radiation induced fibrosis in breast cancer patients. Clin Transl Radiat Oncol Schack LMH, Als TD, Dorling L, Fachal L, Luccarini C, Dunning AM, Dennis J, Overgaard J, Offersen BV, Andreassen CN, Alsner J, Danish Breast Cancer Group DBCG. PMID: 42597731 [PubMed]
	Radiation dose comparison of photon-counting breast CT and mammography: A phantom study. Eur J Radiol Open Cester D, Piol G, Paverd C, Saenger J, Bos D, Shim S, Boss A. PMID: 42597632 [PubMed]
	Real-world outcomes and safety of inetetamab plus pyrotinib and chemotherapy in HER2-positive metastatic breast cancer: A multicenter retrospective study. Ther Adv Med Oncol Wu F, Lin C, Lin Z, Yang Q, Wu X, Chen B, Li N, Zhang R, Wu X, Huang W, Chen X, Hong Y, Chen K, Liu J. PMID: 42597517 [PubMed]
	Prolactin-Linked Plasma Cell-Macrophage Immune Phenotype in Synchronous Bilateral Plasma Cell Mastitis: A Two-Center Prediction Study with Tissue Correspondence. Int J Womens Health Chen W, Li M, Feng J, Qu W, Zhang X, Li S, Sha S, Xue X, Jiang K, Wan H. PMID: 42597281 [PubMed]
	Controllable Cascade Aggregation Ion Programmed Nanomachines and Simple Isolation Enable Tumor-Derived Small Extracellular Vesicles Detection for Enhanced Breast Cancer Assessment. Adv Sci (Weinh) Zhang Z, Liu Z, Meng X, Jiang P, Qu J, Jiang Y, Qiu B, Chen J, Chen P. PMID: 42596902 [PubMed - as supplied by publisher]
	Polyphenolâ€‘based interventions in breast cancer: Signaling pathways, molecular mechanisms and translational therapeutic strategies (Review). Oncol Rep Zeng J, Hu J, Ma Z, Zhu S, Lv X, Zhang L, Shen M, Li T. PMID: 42596834 [PubMed - indexed for MEDLINE]
	Perioperative Changes in Peripheral Natural Killer Cell Activity and Their Association With Clinicopathological Features in Breast Cancer: A Single-Center Cohort Study. Cancer Med Melik MA, Aytekin A, Elçi M, Borazan E. PMID: 42596512 [PubMed - indexed for MEDLINE]
	Pathologic Characteristics of Breast Cancers Detected With Digital Mammography Versus Digital Breast Tomosynthesis: A Pooled Comparative Analysis. Acad Radiol Ferre R, Benefield T, Kuzmiak CM. PMID: 42595635 [PubMed - as supplied by publisher]
	Correspondence on: External vacuum expansion in autologous fat transfer as total breast reconstruction: Is it worth it? The interim analysis of the multicentre randomized controlled EVE trial. J Plast Reconstr Aesthet Surg Chen S, Xia X, Zheng Y, Qin X. PMID: 42595601 [PubMed - as supplied by publisher]
	Volumetric Quantification of Breast Tissue Composition Using Transmission Ultrasound: A Validation Study Against MRI. Ultrasound Med Biol Malik B, Chen JH, Su MY, Wiskin J, Iuanow E. PMID: 42595593 [PubMed - as supplied by publisher]
	NK cells in breast cancer. Trends Immunol Massidda A, Moragon-Terencio S, de Chanville CB, André F, Vivier E, Narni-Mancinelli E. PMID: 42595581 [PubMed - as supplied by publisher]
	Dosimetric parameters of the axillary-lateral thoracic junction in predicting risk of breast cancer-related lymphedema. Radiother Oncol Hong SW, Kim EK, Shin HC, Beom J, Lim JY, Kim IA, Kim K. PMID: 42595256 [PubMed - as supplied by publisher]
	Modern Therapies: Nanotechnology Promises New Approaches for Rare Breast Cancer to Brain Metastases. SLAS Discov Muteeb G, El-Sayed AY, AboHoussien MS, Abuelnile RH, Shaaban AH, Jaafari JIA, Kumari S, Farhan M, Aatif M, Khafaga DSR. PMID: 42595178 [PubMed - as supplied by publisher]
	Aryl Hydrocarbon Receptor Activation by Imidacloprid as a Promoter of HER2(+) Breast Cancer Progression: In silico, in vitro and in vivo studies. Environ Res Buján S, Miret N, Torres D, Pontillo C, Chiappini F, Nicola Candia A, Agustina L, Sofia MM, Bressan M, Scicolone G, Candolfi M, Randi A. PMID: 42595034 [PubMed - as supplied by publisher]
	Drug resistance in breast cancer brain metastasis: mechanisms and therapeutic strategies. Biochim Biophys Acta Rev Cancer Sarker P, Rao SS. PMID: 42594975 [PubMed - as supplied by publisher]
	Unraveling the association between triclosan and breast cancer: A multidimensional research strategy integrating machine learning, mendelian randomization, and molecular dynamics simulations. Environ Int Wu D, Yuan J, Xu H, Yang C, Pan J, Li G, Dai W, Gan J, Jiao J, Wu X. PMID: 42594736 [PubMed - as supplied by publisher]

Articles 1 - 20 / 221137

Page 1 of 11057



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy